{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:10:42Z","timestamp":1789913442613,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T06:27:18Z","timestamp":1424154438000},"page":"1711-1718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses"],"prefix":"10.1016","volume":"33","author":[{"given":"Caroline","family":"Pope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Langton Hewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9693","key":"10.1016\/j.vaccine.2015.02.012_bib0195","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2015.02.012_bib0200","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00006454-200211000-00007","article-title":"Multinational study of pneumococcal serotypes causing acute otitis media in children","volume":"21","author":"Hausdorff","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2015.02.012_bib0205","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/142.5.716","article-title":"Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid","volume":"142","author":"Porro","year":"1980","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2015.02.012_bib0210","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.64.11.4586-4592.1996","article-title":"Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae","volume":"64","author":"Akkoyunlu","year":"1996","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2015.02.012_bib0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006454-199506000-00007","article-title":"Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children \u2013 implications for vaccine strategies","volume":"14","author":"Sniadack","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2015.02.012_bib0220","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination: 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2015.02.012_bib0225","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2015.02.012_bib0230","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/175.2.352","article-title":"Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine","volume":"175","author":"Katz","year":"1997","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.02.012_bib0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0264-410X(93)90004-H","article-title":"Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen","volume":"11","author":"Wilson","year":"1993","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.02.012_bib0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1128\/JCM.25.2.222-225.1987","article-title":"Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin)","volume":"25","author":"Kanclerski","year":"1987","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.02.012_bib0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2005.02.033","article-title":"Structural basis of pore formation by the bacterial toxin pneumolysin","volume":"121","author":"Tilley","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2015.02.012_bib0250","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/IAI.40.2.548-552.1983","article-title":"Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae","volume":"40","author":"Paton","year":"1983","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2015.02.012_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/eji.200535101","article-title":"Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status","volume":"36","author":"Zhang","year":"2006","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.02.012_bib0260","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/512617","article-title":"Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children","volume":"195","author":"Zhang","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2015.02.012_bib0265","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1073\/pnas.0435928100","article-title":"Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection","volume":"100","author":"Malley","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.vaccine.2015.02.012_bib0270","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1128\/IAI.73.10.6479-6487.2005","article-title":"The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease","volume":"73","author":"Srivastava","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2015.02.012_bib0275","doi-asserted-by":"crossref","first-page":"e1001191","DOI":"10.1371\/journal.ppat.1001191","article-title":"Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4","volume":"6","author":"McNeela","year":"2010","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2015.02.012_bib0280","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/IAI.59.7.2297-2304.1991","article-title":"Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide","volume":"59","author":"Paton","year":"1991","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2015.02.012_bib0285","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(98)00225-4","article-title":"Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein","volume":"16","author":"Michon","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.02.012_bib0290","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/IAI.74.1.586-593.2006","article-title":"Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines","volume":"74","author":"Kirkham","year":"2006","journal-title":"Infect Immun"},{"issue":"48","key":"10.1016\/j.vaccine.2015.02.012_bib0295","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1016\/j.vaccine.2011.09.080","article-title":"Characterization of the interactions of the pneumolysoid: delta6 PLY, with human neutrophils in vitro","volume":"29","author":"Cockeran","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.02.012_bib0300","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/JCM.38.1.434-437.2000","article-title":"Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis","volume":"38","author":"Morrison","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.02.012_bib0305","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2015.02.012_bib0310","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0264-410X(99)00511-3","article-title":"The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection","volume":"18","author":"Briles","year":"2000","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2015.02.012_bib0315","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/IAI.70.10.5363-5369.2002","article-title":"Immune responses to novel pneumococcal proteins pneumolysin: PspA, PsaA, and CbpA in adenoidal B cells from children","volume":"70","author":"Zhang","year":"2002","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2015.02.012_bib0320","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.vaccine.2010.02.014","article-title":"Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae","volume":"28","author":"Douce","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.02.012_bib0325","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/IAI.01391-13","article-title":"Mucosal immunization with recombinant fusion protein DnaJ-DeltaA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2015.02.012_bib0330","doi-asserted-by":"crossref","first-page":"e59605","DOI":"10.1371\/journal.pone.0059605","article-title":"Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives","volume":"8","author":"Goulart","year":"2013","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2015.02.012_bib0335","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/infdis\/jit502","article-title":"Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein","volume":"209","author":"Mann","year":"2014","journal-title":"J Infect Dis"},{"issue":"6074","key":"10.1016\/j.vaccine.2015.02.012_bib0340","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.1215947","article-title":"Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes","volume":"335","author":"Cobey","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2015.02.012_bib0345","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.02.012_bib0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2015.02.012_bib0355","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent: interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2015.02.012_bib0360","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1128\/IAI.00773-07","article-title":"Antibody-independent CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins","volume":"75","author":"Basset","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2015.02.012_bib0365","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/bbrc.2001.4297","article-title":"Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins","volume":"281","author":"Baba","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"10.1016\/j.vaccine.2015.02.012_bib0370","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/j.vaccine.2011.03.081","article-title":"Th17\/Th1 biased immunity to the pneumococcal proteins PcsB: StkP and PsaA in adults of different age","volume":"29","author":"Schmid","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2015.02.012_bib0375","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2015.02.012_bib0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.1003143","article-title":"The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia","volume":"187","author":"Witzenrath","year":"2011","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T21:47:49Z","timestamp":1651268869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":38,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X15001784"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}